Adrenergic Receptor Database
 
| Home | Browse | Search | Resource | Submit | Help | About Us |
Receptor List
Structure Info
Receptor Genes
Mutation Info
Ligand Info
Signal Pathway
Related Disease
Targeted Drug
ARDB
Adrenergic Receptors Ligand Information

Synthesis of catecholamines

Tyrosine hydroxylation

The amino acid tyrosine is the starting material. It is taken up into catecholaminergic nerves by an active transport system. Once inside the nerve, an additional hydroxyl group is added to the aromatic ring of tyrosine by the enzyme tyrosine hydroxylase. Tyrosine hydroxylation is the rate limiting step in the synthesis of catecholamines and is subject to feedback inhibition by the end products. This forms the catechol (dihydroxybenzene) part of the molecule responsible for the family name. The product is dihydroxyphenylalanine (DOPA).

DOPA decarboxylation

Dihydroxyphenylalanine (DOPA) is acted upon by aromatic-L-amino acid decarboxylase. This forms dopamine (DA), one of three naturally occurring catecholamines. DOPA is used to treat certain diseases in which it is desired to increased catecholaminergic transmission at certain sites.

Dopamine hydroxylation

DA in catecholaminergic nerves is taken up into synaptic vesicles and is converted to norepinephrine (NE) by the addition of a hydroxyl group on the carbon second (beta) from the amino group (except in a few dopaminergic neurons). Beta hydroxylation is carried out by the enzyme dopamine-beta-hydroxylase (DBH).

N-methylation

DBH is located in the synaptic vesicles so the final step in the synthesis of NE occurs in the vesicle in which NE is packaged along with ATP and other material for eventual release. In adrenal medulla cells, NE in the cytosol is acted upon by phenylethanolamine-N-methyltransferase. This adds a methyl group to the amino nitrogen and forms epinephrine (EPI). The addition of a methyl group significantly alters the pharmacology of the catecholamine. Most of the EPI formed in this process is taken into synaptic vesicles and stored for eventual release into the blood stream. The adrenal medulla releases catecholamines into the blood. In humans, catecholamines released from the adrenal medulla are about 80% EPI and 20% NE. Because these catecholamines are released into the blood and act on receptors in target tissues at some distance these catecholamines act as circulating hormones.

In summary, synthesis of catecholamines is a multistep process. No wonder, then, that instead of being destroyed they are 'recycled' in large part.

Copy Right Reserved to:
Web Site for Cardiovascular and Autonomic Pharmacology,
School of Medicine, University of Washington

 
ARDB is supported by 973 Project in China & 985 Project of Peking University
COPY RIGHT , ARDB, 2002-2003